The new primary care models from HHS will provide greater flexibility to practices that want to participate and deliver care in a different way to reduce hospitalizations, said Travis Broome, vice president of policy at Aledade.
The new primary care models from HHS will provide greater flexibility to practices that want to participate and deliver care in a different way to reduce hospitalizations, said Travis Broome, vice president of policy at Aledade.
Transcript
HHS recently announced its 5 new primary care payment models—what is the importance of having HHS role out these models?
I think it’s really exciting to see the focus on primary care. Secretary [Alex] Azar gave the absolute bet quote if you’re focused on primary care, is that he’s going to elevate the place of primary care in American medicine. And I think the particular care models that came out really offer practices an opportunity to move further away from fee for service, if they want to. Right?
If you want to—these are all voluntary models, if you want to volunteer in the model—by moving to that fixed payment on a monthly basis, by moving to a flat visit rate, practices would have the option, if they want to and think it’s best for them and their patients, to get away from the 15-minute block. The physician’s whole day divided into 15-minute, [Current Procedural Terminology]—driven blocks, and now you could spend, you know, 5 minutes with 1 patient, 30 minutes with another patients, set aside some time for phone calls, and still have a financially viable and successful practice. So that’s great flexibility.
I don’t think it will be for every primary care practice. But for the primary care practices that have been itching for that flexibility, it’s been an amazing option to have, particularly as aligned as it is with accountable care organizations and reducing unnecessary hospitalizations. You know, that’s the one big metric for the new program. You’re going to change the way you get paid and we’re going to pay you more or pay you less depending on how good you do on hospitalizations.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More